SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-122156
Filing Date
2023-04-27
Accepted
2023-04-27 16:10:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d482318ddefa14a.htm DEFA14A 11671
2 GRAPHIC g482318dsp002.jpg GRAPHIC 287296
3 GRAPHIC g482318dsp003.jpg GRAPHIC 221980
  Complete submission text file 0001193125-23-122156.txt   714405
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39460 | Film No.: 23856943
SIC: 2836 Biological Products, (No Diagnostic Substances)